F de Beukelaar - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Epilepsy Research|August 1, 1990

Single-dose efficacy evaluation of loreclezole in patients with photosensitive epilepsyJ Overweg, F De Beukelaar

Cephalalgia : an International Journal of Headache|June 26, 2001

Treatment of migraine attacks with intranasal alniditan: an open studyH C Diener, P Louis, R Schellens, et al.

Pharmaceutical Research|September 1, 1996

Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetic dataA Jadoul, J Mesens, W Caers, et al.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1989

Double-blind cross-over placebo controlled study of flunarizine in patients with therapy resistant epilepsyE Starreveld, F de Beukelaar, A F Wilson, et al.

Clinical Neuropharmacology|June 1, 1988

Double-blind placebo-controlled trial with flunarizine in therapy-resistant epileptic patientsW Fröscher, P Bülau, W Burr, et al.

European Neurology|January 1, 1986

Add-on therapy in epilepsy with calcium entry blockersJ Overweg, D Ashton, F de Beukelaar, et al.

British Journal of Clinical Pharmacology|April 24, 1999

Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacksK I Roon, P A Soons, M P Uitendaal, et al.

Cephalalgia : an International Journal of Headache|September 5, 2001

The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trialH C Diener, P Tfelt-Hansen, F de Beukelaar, et al.

Cephalalgia : an International Journal of Headache|June 6, 2002

Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg dailyH C Diener, J Matias-Guiu, E Hartung, et al.

Epilepsy Research|May 1, 1991

Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-upT Rentmeester, A Janssen, J Hulsman, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Epilepsy Research|August 1, 1990

Single-dose efficacy evaluation of loreclezole in patients with photosensitive epilepsyJ Overweg, F De Beukelaar

Cephalalgia : an International Journal of Headache|June 26, 2001

Treatment of migraine attacks with intranasal alniditan: an open studyH C Diener, P Louis, R Schellens, et al.

Pharmaceutical Research|September 1, 1996

Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetic dataA Jadoul, J Mesens, W Caers, et al.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1989

Double-blind cross-over placebo controlled study of flunarizine in patients with therapy resistant epilepsyE Starreveld, F de Beukelaar, A F Wilson, et al.

Clinical Neuropharmacology|June 1, 1988

Double-blind placebo-controlled trial with flunarizine in therapy-resistant epileptic patientsW Fröscher, P Bülau, W Burr, et al.

European Neurology|January 1, 1986

Add-on therapy in epilepsy with calcium entry blockersJ Overweg, D Ashton, F de Beukelaar, et al.

British Journal of Clinical Pharmacology|April 24, 1999

Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacksK I Roon, P A Soons, M P Uitendaal, et al.

Cephalalgia : an International Journal of Headache|September 5, 2001

The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trialH C Diener, P Tfelt-Hansen, F de Beukelaar, et al.

Cephalalgia : an International Journal of Headache|June 6, 2002

Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg dailyH C Diener, J Matias-Guiu, E Hartung, et al.

Epilepsy Research|May 1, 1991

Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-upT Rentmeester, A Janssen, J Hulsman, et al.

Pageof 2